DR.MAX secures contract for Antineoplastic and Immunomodulating Agents-Framework Agreement Medications from the National Program of Oncology and Volume Cost, PNO22025 code, for a period of 36 months

Romania, Sept. 29 -- Romania based DR.MAX has secured contract from Operator SEAP for Antineoplastic and Immunomodulating Agents-Framework Agreement Medications from the National Program of Oncology and Volume Cost, PNO22025 code, for a period of 36 months. The value of the contract is worth 2457648 RON.

Published by HT Digital Content Services with permission from Pivotal Sources....